Last Updated 15 October 2021.
6 Vaccines Approved for Use in China
-
Anhui Zhifei Longcom
ZF2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 countries
8 trials in 1 country
Approval Source: reuters.com
-
CanSino
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 9 countries
11 trials in 1 country
Approval Source: reuters.com
-
Minhai Biotechnology Co
SARS-CoV-2 Vaccine (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
Approval Source: reuters.com
-
Sinopharm (Beijing)
BBIBP-CorV (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 66 countries
14 trials in 2 countries
Approval Source: reuters.com
-
Sinopharm (Wuhan)
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
8 trials in 7 countries
Approval Source: reuters.com
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 41 countries
22 trials in 1 country
Approval Source: reuters.com
19 Vaccines in Clinical Trials in China
-
Anhui Zhifei Longcom
ZF2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 countries
8 trials in 1 country
-
Clover
SCB-2019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 2 countries
-
West China Hospital
Recombinant (Sf9 cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 4 countries
-
Pfizer/BioNTech
BNT162b1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 2 countries
-
Walvax
mRNA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
CanSino
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 9 countries
11 trials in 1 country
-
Wantai
DelNS1-2019-nCoV-RBD-OPT- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 2 countries
-
Chinese Academy of Medical Sciences
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 2 countries
-
Minhai Biotechnology Co
SARS-CoV-2 Vaccine (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
-
Sinopharm (Beijing)
BBIBP-CorV (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 66 countries
14 trials in 2 countries
-
Sinopharm (Wuhan)
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
8 trials in 7 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 41 countries
22 trials in 1 country
-
National Vaccine and Serum Institute
Recombinant SARS-CoV-2 Vaccine (CHO Cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Shanghai Zerun Biotechnology, Walvax Biotechnology
202-CoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Shenzhen Geno-Immune Medical Institute
LV-SMENP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Livzon Mabpharm Inc
V-01- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
3 trials in 1 country
-
Stemirna Therapeutics Co Ltd
mRNACOVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
AMMS
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Shenzhen Geno-Immune Medical Institute
Covid-19/aAPC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country